These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Chlamydia trachomatis in family planning. Is screening necessary?].
    Author: Guerreiro D, Borrego MJ, Teles Lda C, Catry MD.
    Journal: Acta Med Port; 1996; 9(4-6):151-6. PubMed ID: 9005688.
    Abstract:
    The authors used cellular cultures obtained from endocervix samples in order to determine the predominant factors of infection caused by Chlamydia trachomatis in a population of 391 women who attended a family planning consultation. The authors studied the relation between the infection and the following variables: age, geographical origin, social class, marital status, history of sexually transmitted diseases (STD), risk behaviours, contraceptive methods and attitudes towards both the disease and therapy. Chlamydia trachomatis was isolated in 7 women (1,8%). The highest infection rates were found in the following categories: women between the ages of 35-40 (4,9%), women who resort to hormonal contraception (3,4%), women between the ages of 20-25 (3,2%) and single women and/or women who do not have a regular partner (2,6%). No statistically relevant relation between the above variables and the infection was found, although a relatively high risk was revealed for women who resort to hormonal contraception (O.R = 7,4). The authors have concluded the following: 1. There is no need to proceed with the systematic universal screening of infection caused by Chlamydia trachomatis in the yearly family planning consultations for the low risk STD populations; 2. Hormonal contraception is a factor to be considered when selecting the women to be screened; 3. The yearly gynaecological supervision of women who attend family planning consultations is an important factor in checking the disease; 4. Information on the couple's attitude towards the disease and therapy is essential in the prevention of relapses.
    [Abstract] [Full Text] [Related] [New Search]